Zurcher Kantonalbank (Zurich Cantonalbank) - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,173
-61.4%
17,4590.0%0.00%
Q2 2023$57,440
+14.1%
17,459
+42.6%
0.00%
Q1 2023$50,335
-29.9%
12,2470.0%0.00%
Q4 2022$71,767
+46.5%
12,247
+68.6%
0.00%
Q3 2022$49,000
+44.1%
7,2620.0%0.00%
Q2 2022$34,000
+17.2%
7,2620.0%0.00%
Q1 2022$29,000
-52.5%
7,262
-26.1%
0.00%
Q4 2021$61,000
-35.8%
9,826
-2.6%
0.00%
-100.0%
Q3 2021$95,000
-30.7%
10,092
+0.1%
0.00%0.0%
Q2 2021$137,000
-14.9%
10,081
+1.3%
0.00%0.0%
Q1 2021$161,000
-16.6%
9,947
+37.0%
0.00%0.0%
Q4 2020$193,000
+82.1%
7,262
+28.0%
0.00%0.0%
Q3 2020$106,000
-20.3%
5,6740.0%0.00%0.0%
Q2 2020$133,0005,6740.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$40,026,0004.69%
Opaleye Management Inc. 1,047,000$4,837,0002.18%
Sarissa Capital Management LP 4,299,297$19,863,0002.00%
Decheng Capital Management III (Cayman), LLC 904,268$4,178,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 850,000$3,927,0001.21%
Orbimed Advisors 9,011,437$41,633,0000.75%
Avoro Capital Advisors LLC 7,550,000$34,881,0000.69%
Rock Springs Capital Management LP 4,075,958$18,831,0000.55%
Artal Group S.A. 2,200,000$10,164,0000.54%
DAFNA Capital Management LLC 406,763$1,879,0000.51%
View complete list of MERSANA THERAPEUTICS INC shareholders